John B. Harlow Jr.
At a glance: John B. Harlow Jr. is COO, President at Larimar Therapeutics (LRMR). Their latest SEC Form 4, filed Nov 12, 2026, reported a purchase of $50K. On file: 1 purchase line ($50K) and 0 sale lines ($0).
Disclosed holdings: about $205K of LRMR stock: 67,800 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 13, 2026 close of $3.02. This counts only LRMR shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
COO, President at Larimar Therapeutics, Inc. (LRMR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 12SEC | LRMRLarimar Therapeutics, Inc.First buy | Buy | 17,80067,800 held (+36%) | $2.80 | $50K | +7.7% |
- Buy
COO, President John B. Harlow Jr. bought $50K of LRMR at $2.80 — first open-market purchase in our records; raises the stake by 36%.
Follow John B. Harlow Jr.
Get one email when John B. Harlow Jr. files a new purchase or sale. Free.
At most one email a day about John B. Harlow Jr., plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.